HG

Heena Goyal

Active Director Director DIN 08776714
DIN 08776714 First appointment Jun 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2020
Shareholding value •••• Premium profile

About Heena Goyal

Data last updated:

Heena Goyal is a Director at Akoons Life Sciences Private Limited (since 2020). The company operates in Pharma. Akoons Life Sciences Private Limited reported revenue of ₹12.03 Cr (FY 2024).

DIN 08776714
Primary Designation Director
Industry Pharma
First Appointment 25 Jun 2020
Oldest Company Age 12 yrs
Largest company Akoons Life Sciences Private Limited · ₹12.03 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Akoons Life Sciences Private Limited U51397PB2013PTC038162
Director25 Jun 20202013₹12.03 Cr (FY 2024)Active

Board colleagues of Heena Goyal

Directorship timeline

Open interactive timeline →
Akoons Life Sciences Private Limited
Premium access

Shareholding and investment profile for Heena Goyal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Heena Goyal

Heena Goyal currently holds 1 directorship: Akoons Life Sciences Private Limited (Director, since 25 Jun 2020, revenue ₹12.03 Cr (FY 2024)).

Heena Goyal was first appointed on 25 Jun 2020 as Director at Akoons Life Sciences Private Limited.

The current boards of Heena Goyal's companies include Amit Puri (Akoons Life Sciences Private Limited), Vikrant Goyal (Akoons Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available